Pricing
Login
Home
Charts
Search
Watchlist
Products

Beta Drugs Ltd

BETA
₹1,655.40-6.17%20 Nov 2026
Reports
Pharma Formulations

Beta Drugs Ltd

BETA
₹1,655.40
-6.17%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹1,841Cr
Close
Close Price
₹1,655.40
Industry
Industry
Pharma Formulations
PE
Price To Earnings
33.99
PS
Price To Sales
4.14
Revenue
Revenue
₹444Cr
Rev Gr TTM
Revenue Growth TTM
15.20%
PAT Gr TTM
PAT Growth TTM
27.30%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
88941001038794126137
Growth YoY
Revenue Growth YoY%
-1.20.225.333.0
Expenses
ExpensesCr
70768182707698107
Operating Profit
Operating ProfitCr
1817202117182730
OPM
OPM%
20.918.519.720.619.518.821.822.0
Other Income
Other IncomeCr
-12332322
Interest Expense
Interest ExpenseCr
23344432
Depreciation
DepreciationCr
34444545
PBT
PBTCr
1212161610122226
Tax
TaxCr
33442366
PAT
PATCr
991212991619
Growth YoY
PAT Growth YoY%
-4.80.240.957.8
NPM
NPM%
10.19.611.711.89.89.613.114.0
EPS
EPS₹
9.39.411.612.18.48.914.816.6
QuarterDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
88941001038794126137
Growth YoY
Revenue Growth YoY%
-1.20.225.333.0
Expenses
ExpensesCr
70768182707698107
Operating Profit
Operating ProfitCr
1817202117182730
OPM
OPM%
20.918.519.720.619.518.821.822.0
Other Income
Other IncomeCr
-12332322
Interest Expense
Interest ExpenseCr
23344432
Depreciation
DepreciationCr
34444545
PBT
PBTCr
1212161610122226
Tax
TaxCr
33442366
PAT
PATCr
991212991619
Growth YoY
PAT Growth YoY%
-4.80.240.957.8
NPM
NPM%
10.19.611.711.89.89.613.114.0
EPS
EPS₹
9.39.411.612.18.48.914.816.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
516691116184227296362385444
Growth
Revenue Growth%
30.437.727.958.323.530.222.56.215.2
Expenses
ExpensesCr
41547391141174236288309352
Operating Profit
Operating ProfitCr
9121825435360757692
OPM
OPM%
18.717.919.721.323.223.420.320.619.720.8
Other Income
Other IncomeCr
00011112119
Interest Expense
Interest ExpenseCr
113222371513
Depreciation
DepreciationCr
234771010131718
PBT
PBTCr
781216344149575470
Tax
TaxCr
003491012151317
PAT
PATCr
78912253136424153
Growth
PAT Growth%
18.917.124.5111.823.718.616.4-2.227.3
NPM
NPM%
13.412.210.410.113.513.512.311.710.812.0
EPS
EPS₹
7.88.99.511.625.830.437.942.040.948.7
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
516691116184227296362385444
Growth
Revenue Growth%
30.437.727.958.323.530.222.56.215.2
Expenses
ExpensesCr
41547391141174236288309352
Operating Profit
Operating ProfitCr
9121825435360757692
OPM
OPM%
18.717.919.721.323.223.420.320.619.720.8
Other Income
Other IncomeCr
00011112119
Interest Expense
Interest ExpenseCr
113222371513
Depreciation
DepreciationCr
234771010131718
PBT
PBTCr
781216344149575470
Tax
TaxCr
003491012151317
PAT
PATCr
78912253136424153
Growth
PAT Growth%
18.917.124.5111.823.718.616.4-2.227.3
NPM
NPM%
13.412.210.410.113.513.512.311.710.812.0
EPS
EPS₹
7.88.99.511.625.830.437.942.040.948.7
Sales CAGR
1 Year6%
3 Years19%
5 Years27%
TTM15%
EBITDA CAGR
1 Year1%
3 Years13%
5 Years25%
TTM20%
PAT CAGR
1 Year-2%
3 Years11%
5 Years29%
TTM27%
Avg. ROCE
1 Year18%
3 Years23%
5 Years26%
TTM17%
CFO / EBITDA
1 Year49%
3 Years50%
5 Years51%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
991010101010101011
Reserves
ReservesCr
2432485983113148187235427
Current Liabilities
Current LiabilitiesCr
14323733496385103108144
Non Current Liabilities
Non Current LiabilitiesCr
39131617131213614337
Total Liabilities
Total LiabilitiesCr
5083107118158198254436496656
Current Assets
Current AssetsCr
3243566897128178331335380
Non Current Assets
Non Current AssetsCr
17405149617176105161277
Total Assets
Total AssetsCr
5083107118158198254436496656
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
991010101010101011
Reserves
ReservesCr
2432485983113148187235427
Current Liabilities
Current LiabilitiesCr
14323733496385103108144
Non Current Liabilities
Non Current LiabilitiesCr
39131617131213614337
Total Liabilities
Total LiabilitiesCr
5083107118158198254436496656
Current Assets
Current AssetsCr
3243566897128178331335380
Non Current Assets
Non Current AssetsCr
17405149617176105161277
Total Assets
Total AssetsCr
5083107118158198254436496656

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1708193023313637
Investing Cash Flow
Investing Cash FlowCr
-11-21-15-6-22-19-14-36-51
Financing Cash Flow
Financing Cash FlowCr
5129-8-1-2-7118-8
Net Cash Flow
Net Cash FlowCr
12-925729118-22
Free Cash Flow
Free Cash FlowCr
9-21-71310519-1-16
CFO To PAT
CFO To PAT%
252.91.489.4158.6119.376.184.985.289.9
CFO To EBITDA
CFO To EBITDA%
180.90.947.075.269.444.051.548.549.3
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1708193023313637
Investing Cash Flow
Investing Cash FlowCr
-11-21-15-6-22-19-14-36-51
Financing Cash Flow
Financing Cash FlowCr
5129-8-1-2-7118-8
Net Cash Flow
Net Cash FlowCr
12-925729118-22
Free Cash Flow
Free Cash FlowCr
9-21-71310519-1-16
CFO To PAT
CFO To PAT%
252.91.489.4158.6119.376.184.985.289.9
CFO To EBITDA
CFO To EBITDA%
180.90.947.075.269.444.051.548.549.3

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10991381155446031,1861,9241,2061,841
Price To Earnings
Price To Earnings
16.111.34.19.821.919.632.545.429.134.0
Price To Sales
Price To Sales
2.21.40.41.03.02.64.05.33.14.1
Price To Book
Price To Book
3.32.20.71.75.94.97.59.84.94.2
EV To EBITDA
EV To EBITDA
10.98.93.04.812.711.319.525.616.219.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
32.736.539.237.838.842.638.641.452.352.3
OPM
OPM%
18.717.919.721.323.223.420.320.619.720.8
NPM
NPM%
13.412.210.410.113.513.512.311.710.812.0
ROCE
ROCE%
20.115.918.922.133.231.330.719.417.817.0
ROE
ROE%
20.619.616.517.126.925.023.221.516.912.2
ROA
ROA%
13.69.78.810.015.715.514.39.78.48.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10991381155446031,1861,9241,2061,841
Price To Earnings
Price To Earnings
16.111.34.19.821.919.632.545.429.134.0
Price To Sales
Price To Sales
2.21.40.41.03.02.64.05.33.14.1
Price To Book
Price To Book
3.32.20.71.75.94.97.59.84.94.2
EV To EBITDA
EV To EBITDA
10.98.93.04.812.711.319.525.616.219.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
32.736.539.237.838.842.638.641.452.352.3
OPM
OPM%
18.717.919.721.323.223.420.320.619.720.8
NPM
NPM%
13.412.210.410.113.513.512.311.710.812.0
ROCE
ROCE%
20.115.918.922.133.231.330.719.417.817.0
ROE
ROE%
20.619.616.517.126.925.023.221.516.912.2
ROA
ROA%
13.69.78.810.015.715.514.39.78.48.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr2,7572,1752,1431,8411,5931,4821,403
Close PriceClose₹317.05492.30232.151,655.402,312.00512.65584.85
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE32.4882.4667.6833.9925.8724.43
Price To SalesPS3.663.261.124.144.042.803.65
RevenueRevenueCr7536681,909444395529385
Revenue Growth TTMRev Gr TTM%30.1%10.6%15.2%10.6%12.6%38.4%
PAT Growth TTMPAT Gr TTM%-64.3%127.6%27.3%64.3%1.0%64.2%
Market CapitalizationMkt CapCr2,7572,1752,1431,8411,5931,4821,403
Close PriceClose₹317.05492.30232.151,655.402,312.00512.65584.85
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE32.4882.4667.6833.9925.8724.43
Price To SalesPS3.663.261.124.144.042.803.65
RevenueRevenueCr7536681,909444395529385
Revenue Growth TTMRev Gr TTM%30.1%10.6%15.2%10.6%12.6%38.4%
PAT Growth TTMPAT Gr TTM%-64.3%127.6%27.3%64.3%1.0%64.2%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Annual Reports
Quarterly Reports
Load More
Interviews